PharmEasy, once a shining star in India’s healthtech industry with a $5.6 billion valuation, has seen a dramatic drop in its worth, now valued at just $456 million. This steep decline has come to light after investor Janus Henderson disclosed it had significantly reduced the value of its shares in PharmEasy. What caused this sharp drop, and what does the future hold for the online pharmacy?
